Target intelligence / Profile preview

RN7SK Pseudogene 293 (RN7SKP293)

Target
RN7SKP293
Molecular classification
Other (Pseudogene; not a functional RNA, receptor, enzyme, transporter, etc.[5])
01

Overview

RN7SK pseudogene 293 (RN7SKP293) is a non-functional RNA gene annotation, categorized as a pseudogene related to the genuine 7SK small nuclear RNA (7SK snRNA). Unlike the canonical 7SK snRNA, which is integral to the regulation of transcription elongation through its ribonucleoprotein complex and control of positive transcription elongation factor b (P-TEFb)[1][2][3][4], RN7SKP293 lacks coding potential, structural assembly, or biological activity. There is no evidence for a physiological or clinical function, nor a role in disease, and it is not a therapeutic target[5]. Common database entries refer to sequence homology, but do not ascribe any molecular function to RN7SKP293. If information about a functional target was intended, refer to "7SK small nuclear RNA" (abbreviation: 7SK; canonical name: 7SK small nuclear RNA), which is a well-studied regulator of transcriptional elongation and potential indirect therapeutic interest in oncology and virology[1][2][3][4].

Other names
RNA, 7SK small nuclear pseudogene 293RN7SKP2937SK RNA pseudogene 293

Beyond the preview

Go deeper on RN7SK Pseudogene 293 (RN7SKP293).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RN7SK Pseudogene 293 (RN7SKP293).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call